Key facts
- August AI’s last known valuation is $3.5M (Jun 2024).
- It has raised $4.0M; the latest was Early Stage VC ($3.0M) in Aug 2025.
- Notable investors include Accel, New Enterprise Associates, Pear (California), Claypond Capital Partners, Manipal Global Education Services.
- Status: Privately Held (backing).
- ·The complete investor list — 5 names
- ·Watchlist + deal alerts for August AI
- ·The full record, as it builds
Funding rounds
No funding rounds for August AI are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About August AI
Developer of a health information platform intended to offer personalized medical insights. The company's platform offers a wide range of health-related questions, including interpreting blood reports, understanding medicinal prescriptions, analyzing symptoms, and getting personalized nutritional advice based on the individual's unique profile, enabling users to have access to medical information and emotional support without any cost.
- Sector
- Healthcare
- HQ
- Bengaluru, India
- Founded
- 2022
- Employees
- 19
- Website
- meetaugust.ai/
- Ownership
- Privately Held (backing)
August AI doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in August AI shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on August AI in its N-PORT filings yet. We sweep new filings monthly.